National Resilience Inc., a rapidly growing biomanufacturing company supplying mRNA and sterile-injectable capacity, announced on June 18 that it will relocate its corporate headquarters to Blue Ash, a suburb of Cincinnati. The move accompanies a US$100 million investment to expand the firm’s Ohio sterile-manufacturing campus and is backed by state incentives coordinated through JobsOhio. Resilience said the decision positions the company closer to its largest production facilities and the Midwest’s emerging life-sciences talent pool. Approximately 200 California-based employees will be offered relocation packages or remote-work options; Blue Ash city officials project an eventual 400 new jobs. For mobility managers, the relocation signals continued momentum of “Heartland” biotech clusters competing with traditional coastal hubs. Cost-of-living differentials mean employees who accept transfers could see housing costs drop by 40 percent, but cultural-fit coaching may be required. Ohio’s economic-development team highlighted Butler Tech’s GMP training programme as a workforce pipeline, underscoring the importance of vocational partnerships when companies shift operational cores inland. Resilience retains R&D sites in San Diego and Waltham, so cross-country travel will remain frequent. Travel-policy teams should review airline agreements into Cincinnati/Northern Kentucky International Airport and update per-diem tables for the new HQ region.
Source: Globe Newswire
